Pneumonia testing market size is set to grow by USD 709 million from 2022 to 2027; The rising number of M and A and new product launches are a key trend - Technavio

Rhea-AI Summary

The global pneumonia testing market is anticipated to grow by USD 709 million from 2022 to 2027, with a CAGR of 5.3%.

Key drivers include rising pneumonia prevalence and mortality concerns, spurring demand for timely diagnosis. North America is expected to contribute 32% to market growth, primarily due to the presence of pharmaceutical companies focused on drug development.

However, challenges such as a lack of trained professionals in rural areas may hinder growth. The market is fragmented, with over 15 major vendors, including Abbott Laboratories, Pfizer, and Thermo Fisher Scientific.

Positive

• Market growth projected at USD 709 million from 2022 to 2027.
• CAGR of 5.3% indicates steady growth in pneumonia testing demand.
• North America expected to contribute 32% to overall market growth.

Negative

• Lack of trained professionals poses a significant barrier to market expansion, especially in rural areas.
• High training costs for healthcare staff increase operational expenses for diagnostics centers.

NEW YORK, March 27, 2023 /PRNewswire/ -- The global pneumonia testing market size is estimated to grow by USD 709 million from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 5.3% during the forecast period. The rising number of M&A and new product launches are the primary trend in the market. The addition of new products encourages consumers to purchase a variety of products to test for pneumonia. In addition, the introduction of new products and an increase in M&A will intensify competition in the market, leading to innovation and differentiation. For instance, in February 2021, Thermo Fisher Scientific announced the acquisition of Mesa Biotech Inc. (Mesa Biotech) to expand the molecular diagnostics segment of the company. Hence, such partnerships are expected to fuel the growth of the market in focus during the forecast period. For more insights about the historic data (2017 to 2021) and forecast market size (2023 to 2027) - Request a sample report

Pneumonia Testing Market - Segmentation Assessment Segment Overview
Technavio has segmented the market based on product type (consumables and analyzers) and method (immunodiagnostics, molecular diagnostics, and point-of-care testing). 

• The market growth in the consumables segment will be significant during the forecast period. Consumables used to detect pneumonia contamination include kits and reagents such as PCR assays, nucleic acid detection kits, staining materials, elimination kits and reagents, standards, and controls. Kits and reagents are routinely used in pneumonia tests and often must be purchased from pharmaceutical companies and biomedical research laboratories. For instance, PlasmoTest, a pneumonia detection kit, performs pneumonia tests, which come with reliable assays. These assays can be repurchased individually or along with the kit. Such factors will increase the market growth during the forecast period.

Geography Overview
By geography, the global pneumonia testing market is segmented into North America, Europe, Asia, and Rest of World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the global pneumonia testing market.

• North America is estimated to contribute 32% to the growth of the global market during the forecast period. Rising demand for timely and accurate diagnosis of lung infections and other infections and the presence of several pharmaceutical companies focused on drug development are driving the adoption of pneumonia testing in the region. Such factors will increase the market growth in this region during the forecast period.

Insights about the market contribution of various segments, including country- and region-wise historic data (2017 to 2021) and forecast market size (2023 to 2027) - Download a Sample Report

Pneumonia Testing Market – Vendor Landscape

Technavio has extensively analyzed more than 15 major vendors, including Abbott Laboratories, Acumen Diagnostics Pte Ltd., Becton Dickinson and Co., bioMerieux SA, Bio Rad Laboratories Inc., Danaher Corp., Diamedica SIA, Hologic Inc., Laboratory Corp. of America Holdings, LGC Group, Meridian Bioscience Inc., OpGen Inc., Pfizer Inc., Quest Diagnostics Inc., Quidel Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc, Siemens AG, F. Hoffmann La Roche Ltd., and DiaSorin SpA.

What's New?

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession 
• Global competitiveness and key competitor positions 
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial - buy the report!

Global Pneumonia Testing Market – Market Dynamics Key factor driving market growth

• The rising prevalence of pneumonia and concerns associated with pneumonia mortality are notably driving the market research growth. 
• Pneumonia is widely recognized as one of the most common causes of hospitalization among all infectious diseases.
• If a patient is determined to be seriously ill, they will be hospitalized for further microbiological testing for pneumonia.
• Several poverty-related factors contribute to pneumonia deaths in developing and underdeveloped countries, including malnutrition, lack of safe drinking water and sanitation facilities, outdoor and indoor air pollution, and inadequate access to healthcare.
• The sharp increase in pneumonia-related mortality has, therefore, prompted governments in developing countries to make efforts to improve awareness about pneumonia diagnosis to prevent deaths. Hence, such factors are expected to drive the growth of global market research over the forecast period.

Major challenges hindering market growth

• The lack of trained professionals is a major challenge impeding market growth.
• Most rural hospitals around the world face challenges due to the insufficient number of patients required to justify the use of specialists.
• Additionally, general practitioner appointments are highly expensive, especially at smaller medical institutions.
• Limited public funding for research laboratories and quality assurance contributes to the lack of skills in many developing countries. 
• Therefore, end-users such as hospitals and diagnostic centers need to invest heavily to increase the number of trained professionals by providing training to their employees.
• The training and hiring of professionals increase the cost, which, in turn, will hinder the growth of the global market during the forecast period.

Insights on market drivers, trends, and challenges, historic period (2017 to 2021), and forecast period (2023 to 2027)- Request a sample report!

What are the key data covered in this Pneumonia Testing Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the pneumonia testing market between 2023 and 2027
• Precise estimation of the pneumonia testing market size and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the pneumonia testing market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of pneumonia testing market vendors

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:

• The rapid microbiology testing market is estimated to grow at a CAGR of 9.31% between 2022 and 2027. The size of the market is forecast to increase by USD 2,487.91 million. The increasing incidence of infectious diseases and cancer is notably driving the market growth, although factors such as inadequate healthcare services in developing regions may impede the market growth.
• The microbiology testing market is estimated to grow at a CAGR of 9.98% between 2022 and 2027. The size of the market is forecast to increase by USD 3,012.8 million. The increasing incidence of infectious diseases and cancer is notably driving the market growth, although factors such as inadequate healthcare services in developing regions may impede the market growth. 

Pneumonia Testing Market Scope
Report Coverage	Details
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 5.3%
Market growth 2023-2027	USD 709 million
Market structure	Fragmented
YoY growth 2022-2023 (%)	5.13
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 32%
Key countries	US, China, Japan, Germany, and UK, Canada, Mexico, Italy,Spain, India, Japan, Australia, and South Korea
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Abbott Laboratories, Acumen Diagnostics Pte Ltd., Becton Dickinson and Co., bioMerieux SA, Bio Rad Laboratories Inc., Danaher Corp., Diamedica SIA, Hologic Inc., Laboratory Corp. of America Holdings, LGC Group, Meridian Bioscience Inc., OpGen Inc., Pfizer Inc., Quest Diagnostics Inc., Quidel Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc, Siemens AG, F. Hoffmann La Roche Ltd., and DiaSorin SpA
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse through Technavio's Health Care Market Reports

Table of contents:

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product Type
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Method
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022 

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global pneumonia testing market 2017 - 2021
• Exhibit 18: Historic Market Size – Data Table on Global pneumonia testing market 2017 - 2021 ($ million)

• 4.2 Product Type Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size – Product Type Segment 2017 - 2021 ($ million)

• 4.3 Method Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size – Method Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product Type

• 6.1 Market segments 
• Exhibit 30: Chart on Product Type - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product Type - Market share 2022-2027 (%)

• 6.2 Comparison by Product Type 
• Exhibit 32: Chart on Comparison by Product Type
• Exhibit 33: Data Table on Comparison by Product Type

• 6.3 Consumables - Market size and forecast 2022-2027
• Exhibit 34: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)

• 6.4 Analyzers - Market size and forecast 2022-2027
• Exhibit 38: Chart on Analyzers - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Analyzers - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Analyzers - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Analyzers - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Product Type 
• Exhibit 42: Market opportunity by Product Type ($ million)

7 Market Segmentation by Method

• 7.1 Market segments 
• Exhibit 43: Chart on Method - Market share 2022-2027 (%)
• Exhibit 44: Data Table on Method - Market share 2022-2027 (%)

• 7.2 Comparison by Method 
• Exhibit 45: Chart on Comparison by Method
• Exhibit 46: Data Table on Comparison by Method

• 7.3 Immunodiagnostics - Market size and forecast 2022-2027 
• Exhibit 47: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)

• 7.4 Molecular diagnostics - Market size and forecast 2022-2027 
• Exhibit 51: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)

• 7.5 Point-of-care testing - Market size and forecast 2022-2027 
• Exhibit 55: Chart on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on Point-of-care testing - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Point-of-care testing - Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by Method 
• Exhibit 59: Market opportunity by Method ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 61: Chart on Market share by geography 2022-2027 (%)
• Exhibit 62: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 63: Chart on Geographic comparison
• Exhibit 64: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 China - Market size and forecast 2022-2027
• Exhibit 85: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.10 UK - Market size and forecast 2022-2027
• Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.11 Japan - Market size and forecast 2022-2027
• Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 101: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers 

• 10.2 Market challenges 

• 10.3 Impact of drivers and challenges 
• Exhibit 102: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends 

11 Vendor Landscape

• 11.1 Overview 

• 11.2 Vendor landscape 
• Exhibit 103: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 104: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 105: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 106: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 107: Matrix on vendor position and classification

• 12.3 Abbott Laboratories 
• Exhibit 108: Abbott Laboratories - Overview
• Exhibit 109: Abbott Laboratories - Business segments
• Exhibit 110: Abbott Laboratories - Key news
• Exhibit 111: Abbott Laboratories - Key offerings
• Exhibit 112: Abbott Laboratories - Segment focus

• 12.4 Becton Dickinson and Co. 
• Exhibit 113: Becton Dickinson and Co. - Overview
• Exhibit 114: Becton Dickinson and Co. - Business segments
• Exhibit 115: Becton Dickinson and Co. - Key news
• Exhibit 116: Becton Dickinson and Co. - Key offerings
• Exhibit 117: Becton Dickinson and Co. - Segment focus

• 12.5 bioMerieux SA 
• Exhibit 118: bioMerieux SA - Overview
• Exhibit 119: bioMerieux SA - Business segments
• Exhibit 120: bioMerieux SA - Key offerings
• Exhibit 121: bioMerieux SA - Segment focus

• 12.6 Bio Rad Laboratories Inc. 
• Exhibit 122: Bio Rad Laboratories Inc. - Overview
• Exhibit 123: Bio Rad Laboratories Inc. - Business segments
• Exhibit 124: Bio Rad Laboratories Inc. - Key news
• Exhibit 125: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 126: Bio Rad Laboratories Inc. - Segment focus

• 12.7 Danaher Corp. 
• Exhibit 127: Danaher Corp. - Overview
• Exhibit 128: Danaher Corp. - Business segments
• Exhibit 129: Danaher Corp. - Key news
• Exhibit 130: Danaher Corp. - Key offerings
• Exhibit 131: Danaher Corp. - Segment focus

• 12.8 DiaSorin SpA 
• Exhibit 132: DiaSorin SpA - Overview
• Exhibit 133: DiaSorin SpA - Business segments
• Exhibit 134: DiaSorin SpA - Key news
• Exhibit 135: DiaSorin SpA - Key offerings
• Exhibit 136: DiaSorin SpA - Segment focus

• 12.9 F. Hoffmann La Roche Ltd. 
• Exhibit 137: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 138: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 139: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 140: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 141: F. Hoffmann La Roche Ltd. - Segment focus

• 12.10 Hologic Inc. 
• Exhibit 142: Hologic Inc. - Overview
• Exhibit 143: Hologic Inc. - Business segments
• Exhibit 144: Hologic Inc. - Key news
• Exhibit 145: Hologic Inc. - Key offerings
• Exhibit 146: Hologic Inc. - Segment focus

• 12.11 Laboratory Corp. of America Holdings
• Exhibit 147: Laboratory Corp. of America Holdings - Overview
• Exhibit 148: Laboratory Corp. of America Holdings - Business segments
• Exhibit 149: Laboratory Corp. of America Holdings - Key news
• Exhibit 150: Laboratory Corp. of America Holdings - Key offerings
• Exhibit 151: Laboratory Corp. of America Holdings - Segment focus

• 12.12 Meridian Bioscience Inc. 
• Exhibit 152: Meridian Bioscience Inc. - Overview
• Exhibit 153: Meridian Bioscience Inc. - Business segments
• Exhibit 154: Meridian Bioscience Inc. - Key offerings
• Exhibit 155: Meridian Bioscience Inc. - Segment focus

• 12.13 OpGen Inc. 
• Exhibit 156: OpGen Inc. - Overview
• Exhibit 157: OpGen Inc. - Product / Service
• Exhibit 158: OpGen Inc. - Key offerings

• 12.14 Pfizer Inc. 
• Exhibit 159: Pfizer Inc. - Overview
• Exhibit 160: Pfizer Inc. - Product / Service
• Exhibit 161: Pfizer Inc. - Key news
• Exhibit 162: Pfizer Inc. - Key offerings

• 12.15 Quest Diagnostics Inc. 
• Exhibit 163: Quest Diagnostics Inc. - Overview
• Exhibit 164: Quest Diagnostics Inc. - Business segments
• Exhibit 165: Quest Diagnostics Inc. - Key offerings
• Exhibit 166: Quest Diagnostics Inc. - Segment focus

• 12.16 Quidel Corp. 
• Exhibit 167: Quidel Corp. - Overview
• Exhibit 168: Quidel Corp. - Product / Service
• Exhibit 169: Quidel Corp. - Key offerings

• 12.17 Siemens AG 
• Exhibit 170: Siemens AG - Overview
• Exhibit 171: Siemens AG - Business segments
• Exhibit 172: Siemens AG - Key news
• Exhibit 173: Siemens AG - Key offerings
• Exhibit 174: Siemens AG - Segment focus

13 Appendix

• 13.1 Scope of the report 

• 13.2 Inclusions and exclusions checklist
• Exhibit 175: Inclusions checklist
• Exhibit 176: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 177: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 178: Research methodology
• Exhibit 179: Validation techniques employed for market sizing
• Exhibit 180: Information sources

• 13.5 List of abbreviations 
• Exhibit 181: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/pneumonia-testing-market-size-is-set-to-grow-by-usd-709-million-from-2022-to-2027-the-rising-number-of-m-and-a-and-new-product-launches-are-a-key-trend---technavio-301781432.html

SOURCE Technavio

FAQ

What is the expected growth of the pneumonia testing market by 2027?

The pneumonia testing market is expected to grow by USD 709 million from 2022 to 2027.

What is the projected CAGR for the pneumonia testing market?

The market is projected to grow at a CAGR of 5.3% during the forecast period.

Which region will contribute the most to the pneumonia testing market growth?

North America is estimated to contribute 32% to the global pneumonia testing market growth.

What major challenges does the pneumonia testing market face?

The major challenge is the lack of trained professionals, particularly in rural hospitals.